Hangzhou Alltest Biotech Co., Ltd. (SHA:688606)
China
· Delayed Price · Currency is CNY 54.76
+0.34 (0.62%)
Apr 29, 2026, 3:00 PM CST
Hangzhou Alltest Biotech Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Operating Revenue | 892.24 | 905.34 | 862.37 | 752.26 | 3,387 | 1,873 | Upgrade
|
| Other Revenue | - | - | 4.22 | 2.44 | 1.47 | 0.86 | Upgrade
|
| Revenue | 892.24 | 905.34 | 866.58 | 754.7 | 3,389 | 1,873 | Upgrade
|
| Revenue Growth (YoY) | 1.95% | 4.47% | 14.82% | -77.73% | 80.88% | 64.98% | Upgrade
|
| Cost of Revenue | 443.58 | 444.09 | 392.82 | 380.66 | 1,563 | 843.87 | Upgrade
|
| Gross Profit | 448.66 | 461.25 | 473.77 | 374.04 | 1,826 | 1,030 | Upgrade
|
| Selling, General & Admin | 166.48 | 159.06 | 120.23 | 135.87 | 228.4 | 82.48 | Upgrade
|
| Research & Development | 116.91 | 109.32 | 95.82 | 121.17 | 207.3 | 95.46 | Upgrade
|
| Other Operating Expenses | -11.26 | -14.37 | 9.24 | 6.66 | 27.55 | 9.87 | Upgrade
|
| Operating Expenses | 272.13 | 254.01 | 233.17 | 275.02 | 471.08 | 191.89 | Upgrade
|
| Operating Income | 176.53 | 207.24 | 240.6 | 99.01 | 1,354 | 837.67 | Upgrade
|
| Interest Expense | - | - | -0.42 | -1.46 | -2.17 | -0.67 | Upgrade
|
| Interest & Investment Income | 0.54 | 0.34 | 45.66 | 54.2 | 67 | 44.86 | Upgrade
|
| Currency Exchange Gain (Loss) | - | - | 5.85 | 15.85 | 31.74 | -18.28 | Upgrade
|
| Other Non Operating Income (Expenses) | -9.26 | 6.64 | -1.4 | -1.33 | 0.73 | -3.95 | Upgrade
|
| EBT Excluding Unusual Items | 167.82 | 214.21 | 290.3 | 166.28 | 1,452 | 859.63 | Upgrade
|
| Impairment of Goodwill | - | - | - | - | -14.01 | - | Upgrade
|
| Gain (Loss) on Sale of Investments | 44.13 | 40.61 | 35.55 | 32.67 | -15.22 | 21.33 | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.68 | 0.62 | 1.22 | -0.66 | 0.52 | -0.08 | Upgrade
|
| Asset Writedown | -4.21 | -4.26 | - | -0.28 | -60.7 | - | Upgrade
|
| Other Unusual Items | - | - | 20.65 | -0.57 | 19.11 | 14.65 | Upgrade
|
| Pretax Income | 208.42 | 251.18 | 347.71 | 197.44 | 1,381 | 895.53 | Upgrade
|
| Income Tax Expense | 30.39 | 31.1 | 44.8 | 17.16 | 195.99 | 129.84 | Upgrade
|
| Earnings From Continuing Operations | 178.02 | 220.07 | 302.91 | 180.28 | 1,185 | 765.69 | Upgrade
|
| Minority Interest in Earnings | 0.35 | 0.12 | -0.44 | 0.3 | -0.54 | - | Upgrade
|
| Net Income | 178.37 | 220.19 | 302.47 | 180.58 | 1,185 | 765.69 | Upgrade
|
| Net Income to Common | 178.37 | 220.19 | 302.47 | 180.58 | 1,185 | 765.69 | Upgrade
|
| Net Income Growth | -44.07% | -27.20% | 67.50% | -84.76% | 54.75% | 12.73% | Upgrade
|
| Shares Outstanding (Basic) | 80 | 79 | 79 | 79 | 79 | 75 | Upgrade
|
| Shares Outstanding (Diluted) | 80 | 79 | 79 | 79 | 79 | 75 | Upgrade
|
| Shares Change (YoY) | 0.60% | 0.03% | -0.02% | -0.07% | 5.96% | 25.16% | Upgrade
|
| EPS (Basic) | 2.24 | 2.78 | 3.82 | 2.28 | 14.95 | 10.24 | Upgrade
|
| EPS (Diluted) | 2.24 | 2.78 | 3.82 | 2.28 | 14.95 | 10.24 | Upgrade
|
| EPS Growth | -44.40% | -27.22% | 67.54% | -84.75% | 46.05% | -9.93% | Upgrade
|
| Free Cash Flow | 5.84 | -12.5 | 108.87 | -508.73 | 1,090 | 783.75 | Upgrade
|
| Free Cash Flow Per Share | 0.07 | -0.16 | 1.38 | -6.42 | 13.76 | 10.48 | Upgrade
|
| Dividend Per Share | - | - | 3.000 | 1.500 | 6.757 | 2.703 | Upgrade
|
| Dividend Growth | - | - | 100.00% | -77.80% | 150.00% | 99.99% | Upgrade
|
| Gross Margin | 50.29% | 50.95% | 54.67% | 49.56% | 53.87% | 54.96% | Upgrade
|
| Operating Margin | 19.79% | 22.89% | 27.76% | 13.12% | 39.97% | 44.71% | Upgrade
|
| Profit Margin | 19.99% | 24.32% | 34.90% | 23.93% | 34.97% | 40.87% | Upgrade
|
| Free Cash Flow Margin | 0.65% | -1.38% | 12.56% | -67.41% | 32.18% | 41.84% | Upgrade
|
| EBITDA | 219.49 | 246.77 | 266.44 | 120.18 | 1,378 | 846.45 | Upgrade
|
| EBITDA Margin | 24.60% | 27.26% | 30.75% | 15.92% | 40.65% | 45.18% | Upgrade
|
| D&A For EBITDA | 42.96 | 39.53 | 25.84 | 21.17 | 23.11 | 8.78 | Upgrade
|
| EBIT | 176.53 | 207.24 | 240.6 | 99.01 | 1,354 | 837.67 | Upgrade
|
| EBIT Margin | 19.79% | 22.89% | 27.76% | 13.12% | 39.97% | 44.71% | Upgrade
|
| Effective Tax Rate | 14.58% | 12.38% | 12.88% | 8.69% | 14.19% | 14.50% | Upgrade
|
| Revenue as Reported | - | - | 866.58 | 754.7 | 3,389 | 1,873 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.